Friday, December 18, 2015

Ackman, Sequoia Stock Valeant Changes Course

A pharmaceutical company fueling most of its rapid growth through acquisitions, Valeant (NYSE:VRX) responded to a short-seller’s accusations this week by announcing a change of business model at its 2015 Investor Day.

No comments:

Post a Comment